GMED
Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.
Globus Medical, Inc. (GMED) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Revisions (F).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | B (3.2) | C- (2.1) | B (3.5) | C+ (2.8) | F (0.2) | C (2.3) |
| 2026-11-09 | B (3.2) | C- (2.1) | B (3.4) | C+ (2.6) | F (0.2) | C (2.3) |
| 2026-11-07 | B- (3.1) | C- (1.9) | B (3.5) | C+ (2.6) | D (1.5) | C+ (2.5) |
| 2026-11-06 | B- (3.1) | C- (1.9) | B (3.4) | C+ (2.6) | D+ (1.6) | C+ (2.5) |
| 2026-11-02 | B- (3.1) | C- (1.9) | B (3.4) | C+ (2.6) | D+ (1.7) | C+ (2.5) |